Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine to...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dieplinger, H, Lackner, C, Kronenberg, F, Sandholzer, C, Lhotta, K, Hoppichler, F, Graf, H, König, P
Médium: Artigo
Jazyk:Inglês
Vydáno: 1993
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC287937/
https://ncbi.nlm.nih.gov/pubmed/8432847
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky